# GnRH Agonist as Luteal Support in FET Cycles

> **NCT02620124** · PHASE4 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 100 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Natural cycle: Triptorelin acetate 0.1 mg
- **DRUG:** Hormone replacement cycle and triptorelin acetate 0.1 mg

## Key facts

- **NCT ID:** NCT02620124
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2015-04
- **Final completion:** 2015-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02620124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02620124, "GnRH Agonist as Luteal Support in FET Cycles". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02620124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*